Liver Transplantation in Well-Selected Class III Obese Recipients Yields Good Outcomes

被引:0
|
作者
Yi, Kevin [1 ,2 ]
Avery, Vicki [1 ]
Mccall, John [1 ,2 ]
Giles, Hannah [1 ,2 ]
Lindsay, Helen [3 ]
Gane, Ed [1 ,2 ]
Orr, David [1 ]
Barbier, Louise [1 ,2 ]
机构
[1] Auckland City Hosp, New Zealand Liver Transplant Unit, Te Toka Tumai, Auckland, New Zealand
[2] Univ Auckland, Dept Surg, Auckland, New Zealand
[3] Auckland City Hosp, Anesthesia & Perioperat Care, Te Toka Tumai, Auckland, New Zealand
关键词
liver transplantation; metabolic syndrome; obesity; outcomes; CORONARY-ARTERY-DISEASE; ASSOCIATION; GUIDELINE; MORTALITY; INDEX;
D O I
10.1111/ctr.70060
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: Previous guidelines considered body mass index (BMI) over 40 kg/m(2) a relative contra-indication to liver transplantation (LT). The aims were to examine the selection process and study outcomes of patients with Class I-III obesity. Methods: Retrospective analysis of outcomes of obese patients assessed for LT at our center between 2010 and 2023, divided into three groups: Class I (BMI30-34.9 kg/m(2)), Class II (BMI35-39.9 kg/m(2)), and Class III (BMI>40 kg/m(2)). Survival of non-obese adult patients was used for comparison. Results: Three hundred fifteen patients with BMI >= 30 kg/m(2) were assessed for LT. Seventeen (5.4%) were not wait-listed due to comorbidities. One hundred sixty-eight patients were transplanted: 100 Class I, 43 Class II, and 25 Class III. There were no differences in postoperative complications (Clavien-Dindo Grade 3 or more; 41%, 42%, 48% for Class I-III obesity respectively) or patient and graft survival (5-y rates 84.4% and 82.7%, respectively, for the whole cohort) according to the different classes of obesity. Furthermore, patient and graft survival was not different between non-obese and obese patients (p = 0.932). Conclusion: With a rigorous selection process, short-term outcomes after LT for patients with Class III obesity were comparable to patients with Class I-II obesity. Long-term survival was identical for obese and non-obese patients.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Comparison of hepatitis B prophylactic outcomes in living donor liver transplantation recipients who meet the Milan or UCSF criteria
    Jiang, Li
    Yan, Lu-Nan
    Wen, Tian-Fu
    Li, Bo
    Yang, Jia-Yin
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2013, 12 (05) : 494 - 499
  • [22] Outcomes Among Older Adult Liver Transplantation Recipients in the Model of End Stage Liver Disease (MELD) Era
    Malinis, Maricar F.
    Chen, Shu
    Allore, Heather G.
    Quagliarello, Vincent J.
    ANNALS OF TRANSPLANTATION, 2014, 19
  • [23] Adjusting Cyclophosphamide Dose in Obese Patients with Lymphoma Is Safe and Yields Favorable Outcomes after Autologous Hematopoietic Cell Transplantation
    Bachanova, Veronika
    Rogosheske, John
    Shanley, Ryan
    Burns, Linda J.
    Smith, Sara M.
    Weisdorf, Daniel J.
    Brunstein, Claudio G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : 571 - 574
  • [24] Outcomes of Combined Liver-Kidney Transplantation in Children: Analysis of the Scientific Registry of Transplant Recipients
    Calinescu, A. M.
    Wildhaber, B. E.
    Poncet, A.
    Toso, C.
    McLin, V. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (12) : 2861 - 2868
  • [25] Lipoprotein Profiles in Class III Obese Caucasian and African American Women with Nonalcoholic Fatty Liver Disease
    Garcia, Anna E.
    Kasim, Nader
    Tamboli, Robyn A.
    Gonzalez, Raul S.
    Antoun, Joseph
    Eckert, Emily A.
    Marks-Shulman, Pamela A.
    Dunn, Julia
    Wattacheril, Julia
    Wallen, Taylor
    Abumrad, Naji N.
    Flynn, Charles Robb
    PLOS ONE, 2015, 10 (11):
  • [26] Class III complement component concentrations and modifications in complement polymorphism following orthotopic liver transplantation
    UringLambert, B
    Valette, C
    Hartmann, D
    Wolf, P
    Hauptmann, G
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1995, 19 (12): : 976 - 979
  • [27] Outcomes following liver transplantation from HCV-seropositive donors to HCV-seronegative recipients
    Aqel, Bashar
    Wijarnpreecha, Karn
    Pungpapong, Surakit
    Taner, C. Burcin
    Reddy, Kunam
    Leise, Michael
    Mi, Lanyu
    Dickson, Rolland C.
    JOURNAL OF HEPATOLOGY, 2021, 74 (04) : 873 - 880
  • [28] Do Recipients of Genetically Related Donors Have Better Outcomes After Living Donor Liver Transplantation?
    Choudhary, Narendra S.
    Saha, Sujeet K.
    Saigal, Sanjiv
    Gautam, Dheeraj
    Saraf, Neeraj
    Rastogi, Amit
    Bhangui, Prashant
    Thiagrajan, Srinivasan
    Soin, Arvinder S.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 10 (04) : 334 - 338
  • [29] Living Donor Liver Transplantation for Young Biliary Atresia Recipients Is Associated With Improved Outcomes in the Modern Era
    Ziogas, Ioannis A.
    Yoeli, Dor
    Adams, Megan A.
    Wachs, Michael E.
    Feldman, Amy G.
    Taylor, Sarah A.
    PEDIATRIC TRANSPLANTATION, 2025, 29 (01)
  • [30] Age Matching of Elderly Liver Grafts With Elderly Recipients Does Not Have a Synergistic Effect on Long-term Outcomes When Both Are Carefully Selected
    Gilbo, Nicholas
    Jochmans, Ina
    Sainz-Barriga, Mauricio
    Nevens, Frederik
    van der Merwe, Schalk
    Laleman, Wim
    Verslype, Chris
    Cassiman, David
    Verbeke, Len
    van Malenstein, Hannah
    Roskams, Tania
    Pirenne, Jacques
    Monbaliu, Diethard
    TRANSPLANTATION DIRECT, 2019, 5 (04):